SLSN· Consumer Staples› Household & Personal Products

Solesence, Inc.

Stage 4 · Declining · week 1

As of Oct 22, 2026, Solesence is in Stage 4, the downtrend phase, now in its first week (since Oct 19, 2026). It closed at $0.86, 77.1% below its 52-week high and below its 200-day average, which is falling.

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. More about the company

$0.86

+0.01% today

$60.5M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is SLSN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 27w

S2 17w

S2 28w

S2 13w

S4 26w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 1w → S4 27w → S1 9w → S2 17w → S3 3w → S2 28w → S3 6w → S2 13w → S3 10w → S2 2w → S3 1w → S4 26w → S1 6w → S4 12w → S1 2w → S4 1w current

Total tracked: 165 weeks across 16 stage runs.

SLSN among Household & Personal Products28th of 30 by relative strength

All 30 →

Stocks in Household & Personal Products ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	SKINSkinHealth Systems Inc. Class A	Stage 2 · wk 2	99	+1538.8%
2	ACUAcme United Corporation.	Stage 2 · wk 17	92	+2.5%
3	HELEHelen of Troy Limited	Stage 3 · wk 3	86	−1.9%
4	EPCEdgewell Personal Care Company	Stage 2 · wk 17	86	+6.7%
5	SPBSpectrum Brands Holdings, Inc.	Stage 3 · wk 3	86	−6.3%
6	KVUEKenvue Inc.	Stage 3 · wk 5	82	+12.5%
7	HNSTThe Honest Company, Inc.	Stage 2 · wk 22	80	−6.2%
8	CLColgate-Palmolive Company	Stage 3 · wk 6	74	+14.0%
…28	SLSNSolesence, Inc.	Stage 4 · wk 1	12	+4.9%

vs 52W High

-77.1%

$0.64 lo$3.75 hi

77.1% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 1

1w13w26w

Week 1, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-21.4%

200 DMA: $1.09 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.31x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+4.9%

-8.5%

-22.5%

YTD

-42.7%

-77.0%

Scan Membership

Breakout Watch

Latest: 2025-05-13

6 appearances in last 60 days. First seen: 2020-06-08.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 1 · Vol 1.31x

2026-10-21S4

Wk 1 · Vol 0.46x

2026-10-20S4

Wk 1 · Vol 0.74x

2026-10-19S41→4

Wk 1 · Vol 0.55x

2026-10-16S1

Wk 3 · Vol 0.81x

2026-10-15S1

Wk 3 · Vol 0.96x

2026-10-14S1

Wk 3 · Vol 0.93x

2026-10-13S1

Wk 2 · Vol 0.42x

2026-10-12S1

Wk 2 · Vol 1.81x

2026-10-09S1

Wk 2 · Vol 7.63x

2026-10-08S1

Wk 2 · Vol 1.48x

2026-10-07S1

Wk 2 · Vol 7.90x

Moving averages & range

50 DMA

$0.88

200 DMA

$1.09

52W High

$3.75

52W Low

$0.64

5D Low

$0.86

Resistance levels (recent highs)

20d High

$1.02

60d High

$1.07

120d High

$1.50

250d High

$3.70

Next resistance

+18.6%

to 20d High

ROE

-18.6%

Profit margin -5.3%

Dividend Yield

0.00%

P/B 4.7

Solesence: quick answers

What stage is Solesence in?

As of Oct 22, 2026, Solesence (SLSN) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 19, 2026 and is in its first week there. What the four stages mean

Is Solesence in an uptrend?

No. Solesence is in a Stage 4 downtrend. It trades 21.4% below its 200-day average, which is falling.

How far is Solesence from its 52-week high?

Solesence closed at $0.86 on Oct 22, 2026, 77.1% below its 52-week high of $3.75. Its 52-week low is $0.64.

How has Solesence performed over the past year?

As of Oct 22, 2026, Solesence is down 77.0% over the past year and down 42.7% so far in 2026.

Which sector and industry is Solesence in?

Solesence is in the Household & Personal Products industry, part of the Consumer Staples sector.

About this companyConsumer Staples· Household & Personal Products

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.